期刊文献+

ROCK在卵巢癌组织中的表达及其对卵巢癌细胞增殖与凋亡的影响 被引量:4

Expression of ROCK in epithelial ovarian tumors and its effects on proliferation and apoptosis in ovarian carcinoma cells
下载PDF
导出
摘要 目的:探讨Rho相关卷曲螺旋形成蛋白激酶(Rho-associated coiled-coil forming protein kinase,ROCK)在人卵巢癌组织中的表达及其对人卵巢癌SKOV3细胞增殖和凋亡的影响。方法:免疫组化SP法检测ROCK在80例人卵巢上皮性肿瘤中的表达。用ROCK抑制剂Fasudil处理SKOV3细胞,细胞计数试剂盒(cell counting kit-8,CCK-8)检测细胞增殖,流式细胞仪(flow cytometry,FCM)分析细胞凋亡水平,分光光度法检测半胱氨酸蛋白酶-3(cysteinyl aspartate specific proteinase-3,caspase-3)活性,Western blot检测凋亡相关蛋白p53表达,比较不同浓度Fasudil对细胞增殖、细胞凋亡、caspase-3活性以及凋亡相关蛋白表达的影响。结果:ROCK在恶性卵巢上皮性肿瘤的阳性表达明显高于良性肿瘤(χ2=20.961,P=0.000),在晚期上皮性卵巢癌组织中其表达高于早期肿瘤(χ2=16.675,P=0.000)。不同浓度Fasudil处理组SKOV3细胞24 h增殖抑制率和凋亡率均明显高于未加药组(F=402.537,P=0.000;F=124.251,P=0.000),并均随药物浓度增加而逐渐升高,且Fasudil呈浓度依赖性地增强caspase-3活性(F=32.423,P=0.000)和p53蛋白的表达(F=31.599,P=0.000)。结论:ROCK在卵巢癌组织中有较高表达,可能在卵巢癌细胞增殖和凋亡抑制中扮演一定角色。 Objective:To investigate the expression of Rho-associated coiled-coil forming protein kinase (ROCK) in epithelial ovarian tumors and its effects on proliferation and apoptosis in ovarian carcinoma cells. Methods:Expression of ROCK in 80 patients with epithelial ovarian tumors was assessed by immunohistochemical staining. After being treated with Fasudil, the inhibitor of ROCK, the proliferation and apoptosis of SKOV3 cells were tested by cell counting kit-8 (CCK-8) and flow cytometry(FCM) respectively,the activity of cysteinyl aspartate specific proteinase-3 (caspase-3), caspase-3 was detected by spectrophotometry, and the expression of p53 was detected by Western blot. Results :The expression of ROCK was higher in epithelial ovarian carcinoma tissues than in benign tumors (χ^2=20.961 ,P=0.000), and higher in advanced carcinoma tissues than in early carcinoma tissues (χ^2=16.675,P=0.000). Compared with the untreated SKOV3 cells, the inhibition ratios and apoptosis rates in Fasudil treated cells were increased in an dose dependent relationship (F=402.537, P=0.000 ; F= 124.251, P=0.000). In addition, Fasudil significantly enhanced caspase-3 activity (F= 32.423,P=0.000) and increased the expression of p53 (F=31.599,P=0.000) in concentration-dependent manner. Conclusion:The expression of ROCK is higher in ovarian carcinoma than in benign tumor. ROCK may play a certain role in the proliferation and apoptosis of ovarian carcinoma cells.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2014年第11期1537-1541,共5页 Journal of Chongqing Medical University
基金 国家临床重点专科资助项目(编号:国卫办医函[2013]544号)
关键词 卵巢癌 Rho相关卷曲螺旋形成蛋白激酶 增殖 凋亡 ovarian carcinoma Rho-associated coiled-coil forming protein kinase proliferation apoptosis
  • 相关文献

参考文献17

  • 1Imamura F, Mukai M, Ayaki M,et al.Y-27632,an inhibitor of rho- associated protein kinase,suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase[J].Jpn J Cancer Res,2000, 91 (8) :811-816.
  • 2Ogawa T,Tashiro H,Miyata Y,et al.Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model[J].Am J Transplant, 2007,7 (2) : 347-355.
  • 3Ying H, Biroc SL, Li WW, et al.The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models[J].Mol Can- cer Ther,2006,5(9) :2158-2164.
  • 4Yang X,Di J,Zhang Y,et al.The Rho-kinase inhibitor inhibits pro- liferation and metastasis of small cell lung cancer[J].Biomed Pharma- cother, 2012,66(3) : 221-227.
  • 5Ogata S,Morishige K,Sawada K,et al.Fasudil inhibits lysophos- phatidic acid-induced invasiveness of human ovarian cancer cells[J].Int J Gynecol Cancer,2009,19(9) : 1473-1480.
  • 6Hofiuchi A,Kikuchi N,Osada R,et al.Overexpression of RhoA en- hances peritoneal dissemination:RhoA suppression with Lovastatin may be useful for ovarian cancer[J].Cancer Sci, 2008,99(12) : 2532-2539.
  • 7Brown RS,Wahl RL.Overexpression of glut-1 glucose transporter in human breast cancer.An (10) : 2979-2985. study[J].Cancer, 1993,72.
  • 8Wettschureck N,Offermanns S.Rho/Rho-kinase mediated signaling in physiology and pathophysiology[J].J Mol Med,2002,80(10) :629-638.
  • 9Tamttra M, Nakao H, Yoshizaki H, et al.Development of specific Rho-kinase inhibitors and their clinical application[J].Biochim Biophys Acta, 2005,1754 ( 1-2 ) : 245 -252.
  • 10Otsu K,Sakano M,Masuda T,et al.The role of Rho-kinases in ameloblast differentiation[J].J Oral Bioscienees, 2013,55 (4) : 159-1 64.

二级参考文献29

  • 1王德盛,窦科峰,李开宗,宋振顺,赵青川.Rho/Rho激酶对肝癌细胞体外侵袭转移作用的研究[J].中华普通外科杂志,2005,20(4):245-247. 被引量:7
  • 2于月成,辛晓燕,吴维光,李红梅,李奇灵.Rho和ROCK蛋白在上皮性卵巢癌中的表达及临床意义[J].现代肿瘤医学,2006,14(4):461-464. 被引量:24
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 4Laezza C,Pisanti S,Malfitano A M,et al.The anandamide analog,Met-F-AEA,controls human breast cancer cell migration via the RHOA/ RHO kinase signaling pathway[J].Endocr Relat Cancer,2008,15(4):965-974.
  • 5Bustelo X R,Sauzeau V,Berenjeno I M.GTP-binding proteins of the Rho/Rac family:regulation,effectors and functions in vivo[J].Bioassays,2007,29(4):356-370.
  • 6Gervaise L,Patrice G,Pierre P.Rho kinases in cardiovascular physio-logy and pathophysiology[J].Circ Res,2006,98(3):322-334.
  • 7Nakajima M,Hayashi K,Egi Y,et al.Effect of Wf-536,a novel ROCK inhibitor,against metastasis of B16 melanoma[J].Cancer Chemother Pharmacol,2003,52(4):319-324.
  • 8Zheng R,Iwase A,Shen R,et al.Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase[J].Oncogene,2006,25(44):5942-5952.
  • 9Kaneko K,Yano M,Yamano T,et al.Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter[J].Cancer Res,2001,61:5570 ~ 5574.
  • 10Schmitz AA,Govek EE,Bottner B,et al.Rho GTPases:Signaling,migration,and invasion[J].Exp Cell Res,2000,261:1 ~12.

共引文献32

同被引文献40

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部